AP3491A - Triazolopyridines - Google Patents

Triazolopyridines

Info

Publication number
AP3491A
AP3491A AP2013007182A AP2013007182A AP3491A AP 3491 A AP3491 A AP 3491A AP 2013007182 A AP2013007182 A AP 2013007182A AP 2013007182 A AP2013007182 A AP 2013007182A AP 3491 A AP3491 A AP 3491A
Authority
AP
ARIPO
Prior art keywords
triazolopyridines
Prior art date
Application number
AP2013007182A
Other languages
English (en)
Other versions
AP2013007182A0 (en
Inventor
Hans Briem
Philip Lienau
Antje Margret Wengner
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of AP2013007182A0 publication Critical patent/AP2013007182A0/xx
Application granted granted Critical
Publication of AP3491A publication Critical patent/AP3491A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AP2013007182A 2011-04-21 2012-04-16 Triazolopyridines AP3491A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11163342 2011-04-21
EP11167872 2011-05-27
PCT/EP2012/056914 WO2012143329A1 (en) 2011-04-21 2012-04-16 Triazolopyridines

Publications (2)

Publication Number Publication Date
AP2013007182A0 AP2013007182A0 (en) 2013-10-31
AP3491A true AP3491A (en) 2015-12-31

Family

ID=46124297

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2013007182A AP3491A (en) 2011-04-21 2012-04-16 Triazolopyridines

Country Status (39)

Country Link
US (1) US20140120087A1 (es)
EP (1) EP2699575B1 (es)
JP (1) JP5989091B2 (es)
KR (1) KR20140025470A (es)
CN (1) CN103608350B (es)
AP (1) AP3491A (es)
AR (1) AR086191A1 (es)
AU (1) AU2012244859B2 (es)
CA (1) CA2833657A1 (es)
CL (1) CL2013003044A1 (es)
CO (1) CO6801751A2 (es)
CR (1) CR20130539A (es)
CY (1) CY1116439T1 (es)
DK (1) DK2699575T3 (es)
DO (1) DOP2013000244A (es)
EA (1) EA023766B1 (es)
EC (1) ECSP13013011A (es)
ES (1) ES2539265T3 (es)
GT (1) GT201300254A (es)
HR (1) HRP20150517T1 (es)
HU (1) HUE025496T2 (es)
IL (1) IL228704A0 (es)
JO (1) JO3040B1 (es)
MA (1) MA35049B1 (es)
ME (1) ME02143B (es)
MX (1) MX348783B (es)
MY (1) MY164939A (es)
PE (1) PE20141351A1 (es)
PH (1) PH12013502169A1 (es)
PL (1) PL2699575T3 (es)
PT (1) PT2699575E (es)
RS (1) RS54044B1 (es)
SA (1) SA112330466B1 (es)
SG (1) SG194003A1 (es)
SI (1) SI2699575T1 (es)
TW (1) TWI558703B (es)
UY (1) UY34034A (es)
WO (1) WO2012143329A1 (es)
ZA (1) ZA201308707B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2699558T (pt) 2011-04-21 2016-12-29 Gilead Sciences Inc Compostos de benzotiazole e a sua utilização farmacêutica
UA112096C2 (uk) * 2011-12-12 2016-07-25 Байєр Інтеллектуал Проперті Гмбх Заміщені триазолопіридини та їх застосування як інгібіторів ttk
US9376392B2 (en) 2012-01-04 2016-06-28 Gilead Sciences, Inc. 2-(tert-butoxy)-2-(7-methylquinolin-6-yl) acetic acid derivatives for treating AIDS
US9284323B2 (en) 2012-01-04 2016-03-15 Gilead Sciences, Inc. Naphthalene acetic acid derivatives against HIV infection
CN104284896B (zh) 2012-03-14 2016-06-01 拜耳知识产权有限责任公司 取代的咪唑并哒嗪
HK1206731A1 (en) 2012-07-10 2016-01-15 Bayer Pharma Aktiengesellschaft Method for preparing substituted triazolopyridines
WO2014020043A1 (en) 2012-08-02 2014-02-06 Bayer Pharma Aktiengesellschaft Combinations for the treatment of cancer
WO2014020041A1 (en) 2012-08-02 2014-02-06 Bayer Pharma Aktiengesellschaft Combinations for the treatment of cancer
CN105431435A (zh) * 2013-06-07 2016-03-23 拜耳制药股份公司 具有作为mps-1抑制剂的活性的取代的三唑并吡啶类
CA2914516A1 (en) * 2013-06-07 2014-12-11 Bayer Pharma Aktiengesellschaft Substituted triazolopyridines
CN105246891A (zh) * 2013-06-10 2016-01-13 拜耳制药股份公司 用于治疗癌症的新化合物
HK1221955A1 (zh) * 2013-06-11 2017-06-16 Bayer Pharma Aktiengesellschaft 取代的三唑并吡啶的前体药物衍生物
EA201600003A1 (ru) * 2013-06-11 2016-06-30 Байер Фарма Акциенгезельшафт КОМБИНАЦИИ ДЛЯ ЛЕЧЕНИЯ РАКА, СОДЕРЖАЩИЕ ИНГИБИТОР Mps-1 КИНАЗЫ И ИНГИБИТОР МИТОЗА
EP2860177A3 (en) 2013-09-20 2015-06-10 Bayer Intellectual Property GmbH Synthesis of functionalized arenes
CN107567503B (zh) 2015-04-17 2022-03-22 荷兰转化研究中心有限责任公司 用于ttk抑制剂化疗的预后生物标记
JP7111733B2 (ja) * 2017-03-16 2022-08-02 江蘇恒瑞医薬股▲ふん▼有限公司 ヘテロアリール［４，３－ｃ］ピリミジン－５－アミン誘導体、その製造方法、およびその医薬の使用
WO2020215094A1 (en) 2019-04-18 2020-10-22 The Johns Hopkins University Substituted 2-amino-pyrazolyl-[1,2,4]triazolo[1,5a] pyridine derivatives and use thereof
US11529350B2 (en) 2019-07-03 2022-12-20 Sumitomo Pharma Oncology, Inc. Tyrosine kinase non-receptor 1 (TNK1) inhibitors and uses thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008025821A1 (en) * 2006-08-30 2008-03-06 Cellzome Limited Triazole derivatives as kinase inhibitors
WO2011063908A1 (en) * 2009-11-30 2011-06-03 Bayer Schering Pharma Aktiengesellschaft Triazolopyridines

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US5011472A (en) 1988-09-06 1991-04-30 Brown University Research Foundation Implantable delivery system for biological factors
ES2315909T3 (es) 2004-08-17 2009-04-01 GALDERMA RESEARCH & DEVELOPMENT Nuevos compuestos bioaromaticos que son activadores de los receptores del tipo ppar y su utilizacion en composiciones cosmeticas y farmaceuticas.
PE20090492A1 (es) * 2007-07-18 2009-05-27 Novartis Ag Compuestos heterociclos como inhibidores de cinasa de fosfatidil-inositol-3
CN103298814A (zh) 2007-08-23 2013-09-11 阿斯利康(瑞典)有限公司 作为治疗增殖性疾病的ttk/mps1抑制剂的2-苯胺基嘌呤-8-酮
KR20100075881A (ko) * 2007-08-31 2010-07-05 메르크 세로노 에스. 에이. 트리아졸로피리딘 화합물 및 ａｓｋ 저해제로서 이의 용도
GB0719803D0 (en) 2007-10-10 2007-11-21 Cancer Rec Tech Ltd Therapeutic compounds and their use
SG186040A1 (en) * 2007-11-27 2012-12-28 Cellzome Ltd Amino triazoles as pi3k inhibitors
NZ594508A (en) 2009-02-13 2013-12-20 Fovea Pharmaceuticals [1, 2, 4] triazolo [1, 5 -a] pyridines as kinase inhibitors
EP2424537B1 (en) 2009-04-29 2015-07-08 Bayer Intellectual Property GmbH Substituted imidazoquinoxalines
JP5728683B2 (ja) 2009-09-04 2015-06-03 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ チロシンスレオニンキナーゼ阻害剤としての置換アミノキノキサリン
UY33452A (es) * 2010-06-16 2012-01-31 Bayer Schering Pharma Ag Triazolopiridinas sustituidas

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008025821A1 (en) * 2006-08-30 2008-03-06 Cellzome Limited Triazole derivatives as kinase inhibitors
WO2011063908A1 (en) * 2009-11-30 2011-06-03 Bayer Schering Pharma Aktiengesellschaft Triazolopyridines

Also Published As

Publication number Publication date
PL2699575T3 (pl) 2015-08-31
WO2012143329A1 (en) 2012-10-26
EP2699575A1 (en) 2014-02-26
SI2699575T1 (sl) 2015-10-30
JO3040B1 (ar) 2016-09-05
PE20141351A1 (es) 2014-11-01
PT2699575E (pt) 2015-07-29
JP5989091B2 (ja) 2016-09-07
EA023766B1 (ru) 2016-07-29
IL228704A0 (en) 2013-12-31
AU2012244859B2 (en) 2017-06-08
ECSP13013011A (es) 2013-12-31
MX2013012289A (es) 2013-11-21
US20140120087A1 (en) 2014-05-01
HK1190398A1 (zh) 2014-07-04
PH12013502169A1 (en) 2014-01-13
CN103608350A (zh) 2014-02-26
ES2539265T3 (es) 2015-06-29
ME02143B (me) 2015-10-20
CN103608350B (zh) 2015-11-25
NZ616456A (en) 2015-09-25
KR20140025470A (ko) 2014-03-04
CL2013003044A1 (es) 2014-05-02
EA201301181A1 (ru) 2014-08-29
AU2012244859A1 (en) 2013-10-31
RS54044B1 (sr) 2015-10-30
AR086191A1 (es) 2013-11-27
UY34034A (es) 2012-11-30
CY1116439T1 (el) 2017-02-08
EP2699575B1 (en) 2015-03-25
MA35049B1 (fr) 2014-04-03
GT201300254A (es) 2015-09-01
MX348783B (es) 2017-06-28
HRP20150517T1 (hr) 2015-06-19
MY164939A (en) 2018-02-15
SA112330466B1 (ar) 2015-09-28
SG194003A1 (en) 2013-11-29
TW201245194A (en) 2012-11-16
CR20130539A (es) 2013-12-04
CA2833657A1 (en) 2012-10-26
JP2014511887A (ja) 2014-05-19
AP2013007182A0 (en) 2013-10-31
CO6801751A2 (es) 2013-11-29
TWI558703B (zh) 2016-11-21
ZA201308707B (en) 2016-07-27
DOP2013000244A (es) 2014-03-16
DK2699575T3 (da) 2015-06-22
HUE025496T2 (en) 2016-04-28

Similar Documents

Publication Publication Date Title
DK3505720T3 (en) Cementering under styret tryk
DK3424953T3 (en) Terapeutiske antistoffer
DK2691417T4 (en) Antistof fc-varianter
AP3491A (en) Triazolopyridines
EP2754063A4 (en) EXTENSIBILITY OF THE SMB2 PROTOCOL
EP2776444A4 (en) dihydropteridinones
AP2014007621A0 (en) 2-Thiopyrimidinones
IL227377A0 (en) Combinations
DK2770906T3 (en) Applanationstonometer
GB201109024D0 (en) Can
GB201101727D0 (en) Obuoy
AU4540P (en) BUNNAN Baloskion tetraphyllum
AU5031P (en) BESYS Beschorneria yuccoides
GB201109627D0 (en) Easy clear
AU340282S (en) Can
GB201115238D0 (en) Pit-stop easy
AP00723S1 (en) Autorickshaw
AU338110S (en) Barstool
GB201101931D0 (en) Kerbknight
GB201101204D0 (en) Swiftnut
GB201100055D0 (en) Evac-sac
GB201100308D0 (en) CrossPic
GB201100359D0 (en) Fedorak-a-lope
AU339857S (en) Orchidometer
AU338420S (en) Kettlebell